Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 10

581P - The effect of exercise intervention on defecation related symptoms of colorectal cancer patients a randomized controlled trial

Date

21 Oct 2023

Session

Poster session 10

Topics

Tumour Site

Colon and Rectal Cancer

Presenters

Justin Jeon

Citation

Annals of Oncology (2023) 34 (suppl_2): S410-S457. 10.1016/S0923-7534(23)01935-X

Authors

J. Jeon, D. Park, Y.J. LEE, T.H. Lee, E. Kim, C. Oh, R. Park, J.W. Kang, S. Jun, K. Chiho, S. Yeon

Author affiliations

  • Sports Industry Studies, Yonsei University, 03722 - Seoul/KR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 581P

Background

Although colorectal cancer (CRC) survivors often suffer from defecation related symptoms (DRS), there are very few treatment options to improve DRS. Strengthening of abdominal muscles to increase intra-abdominal pressure and pelvic floor exercises to improve pelvic floor dyssynergia may improve DRS in colorectal cancer patients. However, the effects of exercise on DRS have not been studied fully. Therefore, the purpose of this study is to investigate the efficacy of exercise on DRS in CRC.

Methods

A total of 120 CRC who completed surgery and adjuvants therapy were recruited out of 441 approached. 120 participants were randomly assigned to either exercise (EG) or usual care group (CG). The combined weekly supervised and home-based exercise program (12 weeks) includes increase in physical activity (PA) levels to meet the ACSM guideline as well as daily calisthenics exercises. Calisthenics exercises include a total of 12 movements aimed to increase whole body muscle strengths which focused on core and pelvic floor muscles. The primary outcome was DRS score assessed the sum of blood and mucus in stool, stool frequency, abdominal pain, buttock pain, bloating, flatulence, fecal incontinence and embarrassment in EOTRC-QLQ-CR29. A two-way ANOVA repeated measures were used determine group and time interaction. Table: 581P

Effects of exercise on defecatory symptoms

Control Exercise p-value
Pre Post Pre Post
Blood in stool 4.7 ± 9.7 4.4 ± 9.1 7.2 ± 15.5 3.1 ± 8.9 0.05
Stool frequency 26.3 ± 27.0 20.1 ± 20.5 28.7 ± 25.1 23.4 ± 23.8 0.91
Abdominal pain 14.4 ± 22.4 11.7 ± 19.2 18.3 ± 24.9 10.0 ± 16.6 0.21
Buttock pain 12.2 ± 21.2 12.8 ± 25.4 18.9 ± 30.3 12.8 ± 26.1 0.08
Bloating 22.8 ± 22.5 25.0 ± 25.8 34.4 ± 30.7 22.8 ± 27.1 0.01
Flatulence 21.0 ± 26.0 17.7 ± 23.3 28.3 ± 33.5 21.5 ± 25.1 0.42
Fecal incontinence 13.5 ± 20.5 13.1 ± 20.5 16.9 ± 24.8 12.9 ± 25.3 0.26
Embarrassment 20.4 ± 26.8 16.7 ± 20.8 27.6 ± 32.0 18.0 ± 25.5 0.16

Bolds were statistically significant different between pre and post (p<.05), p= Difference between control vs. exercise

Results

Among the 120 participants enrolled, 100 (96.6%) completed the trial with supervised exercise compliance rate of 95%. PA levels increased and fitness levels improved only in the exercise group. Exercise significantly decreased DRS score (6 week - 0 week: CG= -14.0 ± 54.7 vs. EG= - 56.1 ± 99.5, p for group and time interaction = 0.02). Symptom scores in EG include blood and mucus in stool, abdominal pain, buttock pain, bloating, flatulence and embarrassment were improved.

Conclusions

It is concluded that both combined supervised and home-based exercise significantly reduced bowel and defecatory problems in colorectal cancer patients.

Clinical trial identification

This study was approved by The Institutional Review Board of Severance Hospital (IRB No. 4-2018-0841).

Editorial acknowledgement

This study was funded by the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (HA16C0012020020) and Yonsei Signature Research Cluster Program of 2021-22-0009.

Legal entity responsible for the study

The authors.

Funding

The National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea, Yonsei Signature Research Cluster Program.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.